/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

N

Naoki Kanomata

St. Luke's International Hospital(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

186

Papers

2.3K

Citations

24

h-index

59

i10-index

Naoki Kanomata is an academic researcher from St. Luke's International Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Cancer Genomics and Diagnostics. The author has an h-index of 24, co-authored 159 publications.

ORCID: 0000-0002-0172-4524

Research Topics

Breast Cancer Treatment Studies Breast Lesions and Carcinomas Cancer Genomics and Diagnostics HER2/EGFR in Cancer Research Cancer and Skin Lesions

Papers by this author

works

Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype

2010 · BMC Cancer · 41 citations

https://doi.org/10.1186/1471-2407-10-568

Junichi Kurebayashi Naoki Kanomata Takuya Moriya Yuji Kozuka

Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells

2012 · Breast Cancer · 28 citations

https://doi.org/10.1007/s12282-012-0356-z

Toshiro Shimo Junichi Kurebayashi Naoki Kanomata Tetsumasa Yamashita

Assessment of the Ki67 labeling index: a Japanese validation ring study

2014 · Breast Cancer · 22 citations

https://doi.org/10.1007/s12282-014-0536-0

Naoki Niikura Takashi Sakatani Nobuyuki Arima Yasuyo Ohi

Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions

2020 · BMC Cancer · 21 citations

https://doi.org/10.1186/s12885-020-07432-w

Toshiaki Akahane Naoki Kanomata Oi Harada Tetsumasa Yamashita

Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone

2012 · Breast Cancer · 20 citations

https://doi.org/10.1007/s12282-012-0380-z

Junichi Kurebayashi Naoki Kanomata Toshiro Shimo Tetsumasa Yamashita

CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature

2019 · BMC Cancer · 15 citations

https://doi.org/10.1186/s12885-018-5221-9

Naoki Kanomata Junichi Kurebayashi Yoshikazu Koike Rin Yamaguchi

Research topics

topics

Breast Cancer Treatment Studies

Breast Lesions and Carcinomas

Cancer Genomics and Diagnostics

HER2/EGFR in Cancer Research

Cancer and Skin Lesions

Chat about Author

Papers

Chat

Click to start Chat